Pulmonary hypertension in patients with hemodynamically significant atherosclerotic lesion of a common carotid artery: new pathophysiological mechanisms of the disease

Background. Pulmonary hypertension (PH) is a severe pathology that often leads a patient to death or disability. Recently, the development of PH associated with activation of the sympathetic nervous system (SNS) has been of interest. Some results obtained in an acute experiment on rats showed that activation of the carotid bodies of one external carotid artery is a sufficient stimulus to increase the tone of pulmonary arteries. Obviously, this effect is mediated by the sympathetic nervous system. However, the long-term effects of unilateral hypoxia of the carotid bodies on the morphofunctional state of the pulmonary arteries are not described in the literature. Aim. Effect assessment of common carotid artery bifurcation region ischemia due to the atherosclerotic process on the pulmonary arteries in patients. Materials and methods. The retrospective study was conducted in the Burdenko Neurosurgical Center and in the National Medical Research Center for Cardiology. A total of 60 case histories were analyzed in detail. All patients underwent Duplex scanning of the brachiocephalic arteries, as well as transthoracic echocardiography. The study included patients with atherosclerotic plaque in the area of the common carotid artery bifurcation on either one side or both. Exclusion criteria consisted of diseases that lead to the development of PH. The relationship between the presence of hemodynamically significant atheroma and the development of PH was evaluated. Results. Patients were divided into two groups - those with hemodynamically significant atherosclerotic plaque in the common carotid artery bifurcation region at least on one side (more than 75% of the vascular obstruction) and hemodynamically insignificant atheromas in the common carotid artery bifurcation region on one or both sides (less than 45%). Among patients from the first group, 52.8% of the patients had signs of PH. Among patients from the second group, only 16.7% of the patients had signs of PH. The difference in the frequency of PH occurrence between the two selected groups is statistically significant (p=0.005). There were no differences in red blood cells number, platelets number, glucose concentration and lipid composition of blood plasma. Conclusion. Activation of SNS due to hemodynamically significant atherosclerotic plaque in the area of the bifurcation of the common carotid artery may be an independent mechanism for the development of PH. Key words: pulmonary hypertension, carotid bodies, atherosclerotic plaque, sympathectomy of pulmonary arteries.

pulmonary hypertension, carotid bodies, atherosclerotic plaque, sympathectomy of pulmonary arteries

1. Simonneau G, Galie` N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl. S): 5S-12S. DOI: 10.1016/j.jacc.2004.02.037

2. Чазова И.Е., Авдеев С.Н., Царева Н.А. и др Клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиолог. журн. 2014; 4: 4-24.

3. Verity MA, Bevan JA. Fine structural study of the terminal effector plexus, neuromuscular and intermuscular relationships in the pulmonary artery. J Anat 1968; 103 (Pt 1): 49-63.

4. Langer SZ, Shepperson NB. Postjunctional alpha 1-adrenoceptors: preferential innervation of alpha 1-adrenoceptors and the role of neuronal uptake. J Cardiovasc Pharmacol 1982; 4 (Suppl. 1): S8-13. DOI: 10.1007/BF00165800

5. Kadowitz PJ, Knight DS, Hibbs RG et al. Influence of 5- and 6-hydroxydopamine on adrenergic transmission and nerve terminal morphology in the canine pulmonary vascular bed. Circulation Res 1976; 39 (2): 191-9. DOI: 10.1161/01.res.39.2.191

6. Ciarka A, Doan V, Velez-Roa S et al. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Resp Crit Care Med 2010; 181 (11): 1269-75. DOI: 10.1164/rccm.200912-1856OC

7. Velez-Roa S, Ciarka A, Najem B et al. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 2004; 110 (10): 1308-12. DOI: 10.1161/01.CIR.0000140724.90898.D3

8. Chen SL, Zhang H, Xie DJ et al. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study. Circ Cardiovasc Interv 2015; 8 (11): 28-37. DOI: 10.1161/CIRCINTERVENTIONS.115.002837

9. Chen SL, Zhang FF, Xu J et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol 2013; 62 (12): 1092-100. DOI: 10.1016/j.jacc.2013.05.075

10. Iturriaga R, Castillo-Galán S. Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia. Curr Hypertens Rep 2019; 21 (11): 89. DOI: 10.1007/s11906-019-0995-y

11. Данилов Н.М., Чен Ш., Сагайдак О.В. и др. Радиочастотная денервация легочной артерии у пациентки с идиопатической легочной гипертензией. Кардиологический вестник. 2014; 9 (2): 102-4.

12. Sugito K, Tatsumi K, Igari H et al. Role of carotid body in pressure response of pulmonary circulation in rats. Respiration Physiology 1998; 111 (3): 283-93. DOI: 10.1016/s0034-5687(97)00126-6

13. Liu C, Jiang XM, Zhang J et al. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system. BMC Cardiovasc Dis 2016; 16 (1): 192. DOI: 10.1186/s12872-016-0366-4

14. Chen SL, Zhang YJ, Zhou L et al. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013; 9 (2): 269-76. DOI: 10.4244/EIJV9I2A43

15. Na S, Kim OS, Ryoo S et al. Cervical ganglion block attenuates the progression of pulmonary hypertension via nitric oxide and arginase pathways. Hypertension 2014; 63 (2): 309-15. DOI: 10.1161/HYPERTENSIONAHA.113.01979

16. Rothman AM, Arnold ND, Chang W et al. Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension. Circulation Cardiovasc Intervent 2015; 8 (11): 25-69. DOI: 10.1161/CIRCINTERVENTIONS.115.002569

17. Vaillancourt M, Chia P, Sarji S et al. Autonomic nervous system involvement in pulmonary arterial hypertension. Resp Res 2017; 18 (1): 201. DOI: 10.1186/s12931-017-0679-6

18. Zhou L, Zhang J, Jiang XM et al. Pulmonary artery denervation attenuates pulmonary arterial remodeling in dogs with pulmonary arterial hypertension induced by dehydrogenized monocrotaline. JACC. Cardiovasc Intervent 2015; 8 (15): 2013-23. DOI: 10.1016/j.jcin.2015.09.015